Back to 
CITADEL ADVISORS LLC
CITADEL ADVISORS LLC
DWTX1 quarters
Position history for CITADEL ADVISORS LLC's holdings in DOGWOOD THERAPEUTICS INC
Yes. Citadel Advisors holds 11,742 shares of DWTX (Dogwood Therapeutics), worth $18,905, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$18,905
Current Shares
11,742
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of DWTX: MILLENNIUM MANAGEMENT LLC, VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC